Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gaynor LT"'
Autor:
Gaynor LT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Graduate Program in Biological & Biomedical Sciences, Harvard Medical School, Boston, MA, USA., Shivdasani RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Ramesh_Shivdasani@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. Ramesh_Shivdasani@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. Ramesh_Shivdasani@dfci.harvard.edu.
Publikováno v:
Cell research [Cell Res] 2022 Mar; Vol. 32 (3), pp. 225-226.
Autor:
McCarthy N; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Manieri E; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Storm EE; Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA., Saadatpour A; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Kapoor VN; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA., Madha S; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gaynor LT; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Graduate Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA., Cox C; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA., Keerthivasan S; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA., Wucherpfennig K; Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Yuan GC; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02139, USA., de Sauvage FJ; Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA., Turley SJ; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA., Shivdasani RA; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02139, USA. Electronic address: ramesh_shivdasani@dfci.harvard.edu.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2020 Mar 05; Vol. 26 (3), pp. 391-402.e5. Date of Electronic Publication: 2020 Feb 20.
Autor:
Cheng CW; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Biton M; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Haber AL; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Gunduz N; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800 Ankara, Turkey., Eng G; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Department of Pathology, Massachusetts General Hospital Boston and Harvard Medical School, Boston, MA 02114, USA., Gaynor LT; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Tripathi S; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Calibasi-Kocal G; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Dokuz Eylul University, Institute of Oncology, Department of Translational Oncology, Izmir, Turkey., Rickelt S; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Butty VL; BioMicro Center at MIT, Department of Biology, MIT, Cambridge, MA 02139, USA., Moreno-Serrano M; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Iqbal AM; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Bauer-Rowe KE; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA., Imada S; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan., Ulutas MS; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Department of Biology, Siirt University, Science and Arts Faculty, 56100 Siirt, Turkey., Mylonas C; Department of Biology, MIT, Cambridge, MA 02139, USA., Whary MT; Division of Comparative Medicine, Department of Biological Engineering, MIT, Cambridge, MA 02139, USA., Levine SS; BioMicro Center at MIT, Department of Biology, MIT, Cambridge, MA 02139, USA., Basbinar Y; Dokuz Eylul University, Institute of Oncology, Department of Translational Oncology, Izmir, Turkey., Hynes RO; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Department of Biology, MIT, Cambridge, MA 02139, USA., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital Boston and Harvard Medical School, Boston, MA 02114, USA., Deshpande V; Department of Pathology, Massachusetts General Hospital Boston and Harvard Medical School, Boston, MA 02114, USA., Boyer LA; Department of Biology, MIT, Cambridge, MA 02139, USA., Fox JG; Division of Comparative Medicine, Department of Biological Engineering, MIT, Cambridge, MA 02139, USA., Terranova C; Genomic Medicine Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rai K; Genomic Medicine Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Piwnica-Worms H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mihaylova MM; Department of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH 43210 USA., Regev A; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Department of Biology, MIT, Cambridge, MA 02139, USA., Yilmaz ÖH; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA; Department of Biology, MIT, Cambridge, MA 02139, USA; Department of Pathology, Massachusetts General Hospital Boston and Harvard Medical School, Boston, MA 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: ohyilmaz@mit.edu.
Publikováno v:
Cell [Cell] 2019 Aug 22; Vol. 178 (5), pp. 1115-1131.e15.
Autor:
Gracz AD; 1] Department of Cell Biology &Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Williamson IA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Roche KC; Department of Cell Biology &Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Johnston MJ; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Wang F; Department of Pathology and Laboratory Medicine, University of Kansas, Kansas City, Kansas 66160, USA., Wang Y; Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill North Carolina 27599, USA., Attayek PJ; UNC/NC State Biomedical Engineering, Chapel Hill North Carolina 27599, USA., Balowski J; Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill North Carolina 27599, USA., Liu XF; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Laurenza RJ; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Gaynor LT; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Sims CE; Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill North Carolina 27599, USA., Galanko JA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Li L; 1] Department of Pathology and Laboratory Medicine, University of Kansas, Kansas City, Kansas 66160, USA [2] Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA., Allbritton NL; 1] Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill North Carolina 27599, USA [2] UNC/NC State Biomedical Engineering, Chapel Hill North Carolina 27599, USA., Magness ST; 1] Department of Cell Biology &Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [3] UNC/NC State Biomedical Engineering, Chapel Hill North Carolina 27599, USA.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2015 Mar; Vol. 17 (3), pp. 340-9. Date of Electronic Publication: 2015 Feb 09.